Remove Conditions Remove Data Remove Magazine Remove Patients
article thumbnail

Why is US Cannabis Research Funded to Focus on Adverse Effects?

Veriheal

Daniel Mallinson, a cannabis policy researcher, reviewed the funding analysis provided to Science Magazine and stated that, “The government’s budget is a political statement about what we value as a society. The data for this graphic was provided by Jim Hudson at Hellth.com. . The results are as follows. Canada, and the U.K)

article thumbnail

Prohibitionists want THC-limit laws. Here’s why patients and consumers are fighting back

SpeedWeed

Forcing patients to purchase more. Doing so, Pollara wrote, would effectively force a 50% to 150% tax on patients. It is also the one which produces the most and strongest medicinal effects for patients. Patients will feel the effects of THC caps almost immediately,” Pollara added. Here’s how Pollara explained it: .

THC 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Gen Z Women Are the Quickest Growing Group of Cannabis Consumers

Veriheal

The news outlet used data from Headset to explain that Gen Z women who purchased cannabis grew by 151%, with the Gen Z men sitting at a 118% increase in legal purchases. According to the Headset data, flower purchases dominate in both genders but women tend to navigate towards pre-rolled joints, edibles, and beverages more than men.

Data 104
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S. If you enjoyed this Freedom Leaf article, subscribe to the magazine today! A month later, on May 16, the Department of Health and Human Services approved the FDA’s Epidiolex recommendation.

DEA 51
article thumbnail

Eurofins Core Business Sets Record Performance in Q2 2021 With 25% Organic Growth Year-on-year

Cannabis Law Report

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. Eurofins’ Clinical Diagnostics business in North America continues to innovate new testing methods to expand its services for transplant patients.

Business 105
article thumbnail

July 18: Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review

Cannabis Law Report

Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. The report card also says that medical care for the patients involved was happening without supervision from a qualified investigator. CBC Canada.

Safety 52
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.